Ghassan K. Abou-Alfa, MD
Advertisement
Articles by Ghassan K. Abou-Alfa, MD
Advertisement
Latest Updated Articles
Safety Profiles of Available Therapies in Advanced HCCPublished: August 9th 2023 | Updated:
Therapy for Locally Advanced HCCPublished: January 5th 2023 | Updated:
- Child-Pugh Scoring System and Liver Function Assessment
Published: January 5th 2023 | Updated:
- The Future of HCC Treatment
Published: August 9th 2023 | Updated:
Dr. Abou-Alfa on Significance of RESORCE Trial for HCCPublished: July 26th 2016 | Updated:
Dr. Abou-Alfa on Trial of MEK162 in Advanced Biliary CancerPublished: April 3rd 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5